Product
Mesopher
1 clinical trial
1 indication
Indication
Mesothelioma, Malignant, PleuralClinical trial
Phase I, Open-Label Study With Dendritic Cell Therapy (MesoPher) In Combination With Ex-tended-Pleurectomy/Decortication After Chemotherapy in Subjects With Resectable MesotheliomaStatus: Recruiting, Estimated PCD: 2024-12-31